๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Advanced Hodgkin Lymphoma

Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL NCT07234487Phase 23 sites๐Ÿ“ Moscow๐Ÿ“ Moscow๐Ÿ“ Saint Petersburg St. Petersburg State Pavlov Medical University ยท Tests: Nivo-AVD, BEACOPP-like A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. NCT06022029Phase 116 sites๐Ÿ“ Los Angeles๐Ÿ“ Tamarac๐Ÿ“ Canton OncoNano Medicine, Inc. ยท Tests: ONM-501, Cemiplimab The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies NCT04329728Phase 1, Phase 211 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles AVM Biotechnology Inc ยท Tests: AVM0703 Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer NCT07215910Phase 3152 sites๐Ÿ“ Bakersfield๐Ÿ“ Duarte๐Ÿ“ Dublin Alliance for Clinical Trials in Oncology ยท Tests: Intensity-Modulated Radiation Therapy, Volume Modulated Arc Therapy, Pencil Beam Scanning, Intensity-Modulated Proton Tโ€ฆ A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer NCT05659732Phase 15 sites๐Ÿ“ Clayton๐Ÿ“ Kaohsiung City๐Ÿ“ Taichung PharmaEngine ยท Tests: PEP07 Study of AXT-1003 in Subjects With Advanced Malignant Tumors. NCT06484985Phase 15 sites๐Ÿ“ Beijing๐Ÿ“ Changsha๐Ÿ“ Fuzhou Axter Therapeutics (Beijing) Co., Ltd ยท Tests: AXT-1003 Nivo40-AVD for Advanced Classic Hodgkin Lymphoma NCT06984146Phase 21 site๐Ÿ“ Moscow National Medical Research Radiological Centre of the Ministโ€ฆ ยท Tests: Nivolumab, Doxorubicin, Vinblastine, Dacarbazine Pianzumab Combined With AVD Regimen in the Treatment of Newly-diagnosed Advanced Classic Hodgkin Lymphoma NCT05949931Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Concurrent penpulimab and AVD, Sequential penpulimab and AVD Evaluate the Safety and Clinical Activity of HH2853 NCT04390737Phase 1, Phase 225 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Rochester Haihe Biopharma Co., Ltd. ยท Tests: HH2853 Tablets A Clinical Trial to Evaluate Effect of IBD0333 in Patients With Advanced Malignant Tumors NCT06292208Phase 1, Phase 21 site๐Ÿ“ Jinan SUNHO๏ผˆChina๏ผ‰BioPharmaceutical CO., Ltd. ยท Tests: IBD0333 Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study NCT06534762Phase 21 site๐Ÿ“ Hangzhou Zhejiang Provincial People's Hospital ยท Tests: Mirabegron Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) NCT03297606Phase 210 sites๐Ÿ“ Edmonton๐Ÿ“ Kelowna๐Ÿ“ Vancouver Canadian Cancer Trials Group ยท Tests: Olaparib, Dasatinib, Nivolumab plus Ipilimumab, Axitinib, Bosutinib Swedish Cardiac And Renal Failure Study-1 NCT07029503Phase 21 site๐Ÿ“ Stockholm Karolinska Institutet ยท Tests: Eplerenone IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas NCT05365659Phase 113 sites๐Ÿ“ Baltimore๐Ÿ“ Westmead๐Ÿ“ Adelaide Iksuda Therapeutics Ltd. ยท Tests: IKS03 A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas NCT04104776Phase 1, Phase 280 sites๐Ÿ“ Tampa๐Ÿ“ Atlanta๐Ÿ“ Chicago Novartis Pharmaceuticals ยท Tests: Tulmimetostat, Enzalutamide Fixed-Duration Zanubrutinib, Bendamustine, and Obinutuzumab (ZBG) in Treatment-Naรฏve Advanced Stage Follicular Lymphoma NCT07126678NA1 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: zanubrutinib, bendamustine, and obinutuzumab PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma NCT07209059Phase 21 site๐Ÿ“ Moscow National Research Center for Hematology, Russia ยท Tests: Nivolumab, N-EACOPD-14, N-AVD Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas NCT05956041Phase 21 site๐Ÿ“ Ann Arbor University of Michigan Rogel Cancer Center ยท Tests: Pembrolizumab, Mogamulizumab Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment NCT07422610Phase 110 sites๐Ÿ“ Bordeaux๐Ÿ“ Saint-Herblain๐Ÿ“ Milan Novartis Pharmaceuticals ยท Tests: pelabresib Evaluation of Skin Tests in Biotherapy Allergies NCT06971848NA1 site๐Ÿ“ Angers University Hospital, Angers ยท Tests: Drug skin tests (investigating hypersensitivity to a biotherapy) TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer NCT02693535Phase 2181 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Auburn American Society of Clinical Oncology ยท Tests: Sunitinib (CLOSED TO ENROLLMENT), Trastuzumab and Pertuzumab (CLOSED TO ENROLLMENT), Vemurafenib and Cobimetinib (CLOSEโ€ฆ Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma NCT03719105EARLY Phase 16 sites๐Ÿ“ Birmingham๐Ÿ“ Orange๐Ÿ“ San Francisco New York Medical College ยท Tests: Methotrexate, pralatraxate,, Ifosfamide, Dexamethasone, Etoposide Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN) NCT01853631Phase 12 sites๐Ÿ“ Houston๐Ÿ“ Houston Baylor College of Medicine ยท Tests: Dose Escalation Phase:CD19.CAR/28 and CD19.CAR/28137 T cells, Expansion Phase: CD19.CAR/28 and CD19.CAR/28137 T cells Immunotherapy in Lymphoma NCT06796517n/a2 sites๐Ÿ“ Seoul๐Ÿ“ Seoul Sung-Soo Park ยท Tests: CAR-T Therapy, Bispecific antibody, Antibody-Drug Conjugate, Monoclonal antibody, Proteasome Inhibitor A Study of NX-1607 in Adults With Advanced Malignancies NCT05107674Phase 117 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ San Francisco Nurix Therapeutics, Inc. ยท Tests: NX-1607, Paclitaxel Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma NCT06745076Phase 26 sites๐Ÿ“ Irvine๐Ÿ“ Palo Alto๐Ÿ“ Boston University of Washington ยท Tests: Biospecimen Collection, Computed Tomography, Dacarbazine, Doxorubicin, Echocardiography Test Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma NCT06445517Phase 14 sites๐Ÿ“ Beijing๐Ÿ“ Nanchang๐Ÿ“ Shanghai InSilico Medicine Hong Kong Limited ยท Tests: ISM8207 Study Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced Lymphoma NCT06755450Phase 119 sites๐Ÿ“ Vadodara๐Ÿ“ Jhajjar๐Ÿ“ Bangalore Aurigene Discovery Technologies Limited ยท Tests: AUR112 A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma. NCT06393738Phase 121 sites๐Ÿ“ New Haven๐Ÿ“ Miami๐Ÿ“ Detroit Arvinas Inc. ยท Tests: ARV-393, Glofitamab A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPฮฑ-CD47 Pathway, in Solid or Hematological Tumors NCT05892718Phase 18 sites๐Ÿ“ Port Saint Lucie๐Ÿ“ Huntersville๐Ÿ“ Greenville FBD Biologics Limited ยท Tests: HCB101
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy